PARIS–(BUSINESS WIRE)–Juvisé acquiert les droits mondiaux (hors Etats-Unis/Canada) de PONVORY® pour le traitement de la SEP et ouvre son capital à Bpifrance et Pemberton
Business Wire Merger/Acquisition News
Enjoying Merger Arbitrage Limited?
Sign up then! It's quick and FREE
Have time to share an article? It's very much appreciated!!